论文部分内容阅读
目的:探讨SPECT显像在131I治疗分化型甲状腺癌的临床价值。方法:选取80例甲状腺癌利用SPECT全身扫描和SPECT联合断层显像仪融合扫描131I治疗后的患者,观察甲状腺癌转移灶存在部位和残留组织。结果:经131I治疗的SPECT全身显像和融合显像均能比较清楚地确定甲状腺残留组织和转移灶部位,比较而言131ISPECT与其他类型扫描仪融合显像发现病灶的数目多。结论:SPECT显像(无论是融合显像还是全身显像)能帮助监测、定位分化型甲状腺癌残留和转移灶部位,SPECT融合其他扫描仪监测定位更准确。
Objective: To investigate the clinical value of SPECT imaging in 131I treatment of differentiated thyroid cancer. Methods: Eighty patients with thyroid cancer who had undergone thyroidectomy with SPECT and SPECT combined with 131I were enrolled in this study. The metastable sites and residual tissues of thyroid cancer were observed. Results: 131I-SPECT whole body imaging and fusion imaging were able to more clearly determine the residual thyroid tissue and metastasis sites, compared with 131ISPECT fusion imaging with other types of scan found in the number of lesions. Conclusion: SPECT imaging (either fusion imaging or whole-body imaging) can help monitor and locate differentiated thyroid cancer residues and metastatic sites. SPECT fusion and other scanners can monitor and locate more accurately.